Pierre Fabre Pharma GmbH
🇩🇪Germany
Clinical Trials
7
Active:1
Completed:4
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Recruiting
- Conditions
- Metastatic Colorectal Carcinoma
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 500
- Registration Number
- NCT04673955
- Locations
- 🇩🇪
Clinic, Berlin, Germany
🇩🇪Practice, Hamburg, Germany
🇩🇪Medical Care Centre, Berlin, Germany
Real-life Pan-HER-blockade With Neratinib
Active, not recruiting
- Conditions
- Breast Neoplasm
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 304
- Registration Number
- NCT04388384
- Locations
- 🇨🇭
Clinic, Zürich, Switzerland
🇩🇪Medical Practice, Bremen, Germany
🇩🇪Community Health Center, Neuss, North Rhine-Westphalia, Germany
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Recruiting
- Conditions
- Melanoma Stage IVMelanoma Stage III
- First Posted Date
- 2019-08-05
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 750
- Registration Number
- NCT04045691
- Locations
- 🇦🇹
11, Graz, Austria
🇦🇹13, Innsbruck, Austria
🇦🇹14, Klagenfurt, Austria
Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria
Completed
- Conditions
- Non-Small-Cell Lung CancerBreast Cancer
- First Posted Date
- 2015-12-02
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 108
- Registration Number
- NCT02619929
JAVLOR® Online Non-Interventional Trial
Completed
- Conditions
- Transitional Cell Carcinoma
- First Posted Date
- 2010-04-14
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 200
- Registration Number
- NCT01103544
- Locations
- 🇩🇪
Pierre Fabre Pharma GmbH, Freiburg, Germany
- Prev
- 1
- 2
- Next
News
No news found